---
nav_exclude: true
title: "Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=603187"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2022-03-17
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine as effective in protecting against Omicron infection among children and adolescents. 

## 詳細內容

This report describes vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine as effective in protecting against Omicron infection among children and adolescents. 

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:12:39Z*
*資料來源: CDC MMWR*
